$7.24
0.253.58%
At close: -
$7.22
-0.02-0.28%
After Hours: 4:57 PM EDT
Recursion Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Recursion Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.34 | $-0.35 | 2.86 % |
Jun 2024 | 2024-08-08 | $-0.40 | $-0.40 | 0.00 % |
Mar 2024 | 2024-05-09 | $-0.39 | $-0.42 | 7.14 % |
Dec 2023 | 2024-02-27 | $-0.42 | $-0.45 | 6.67 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $26.08M | $29.84M | -12.6 % |
Jun 2024 | 2024-08-08 | $14.42M | $13.75M | 4.85 % |
Mar 2024 | 2024-05-09 | $13.49M | $12.65M | 6.65 % |
Dec 2023 | 2024-02-27 | $10.89M | $20.53M | -46.9 % |
Recursion Pharmaceuticals (RXRX) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-0.34, which beat the estimate of $-0.35.
The Actual Revenue was $26.1M, which missed the estimate of $29.8M.
Browse earnings estimates, EPS, and revenue on all stocks.